当前位置: 首页 > 详情页

Paeoniflorin protects HUVECs from AGE-BSA-induced injury via an autophagic pathway by acting on the RAGE.

| 认领 | 导出 |

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Endocrinology, Second Affiliated Hospital of Soochow University, Suzhou 215004, China [2]Department of Neurology, Second Affiliated Hospital of Soochow University, Suzhou 215004, China. *Equal contributors
出处:
ISSN:

关键词: Human umbilical vein endothelial cells (HUVECs) advanced glycation end products (AGEs) receptor for advanced glycation end products (RAGE) paeoniflorin (PF) autophagy flux

摘要:
The aim of our study was to investigate the protective effects of Paeoniflorin (PF) against injury induced by AGE-modified bovine serum albumin (AGE-BSA) in human umbilical vein endothelial cells (HUVECs), and to examine the underlying mechanisms of these effects. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was used to determine cell viability. Protein expression levels were determined by western blotting. For function-blocking experiments, we used small interfering RNA molecules (siRNA) for function-blocking experiments. At 6 h, we found that 100 μg/mL AGE-BSA reduced the viability of HUVECs. However, pretreatment with PF restored cell viability in a dose-dependent manner. AGE-BSA increased the levels of microtubule-associated protein light chain 3-II (LC3-II) and the receptor for advanced glycation end products (RAGE). Expression of p62 protein was also increased, but not at a statistically significant level. Pretreatment with PF further increased levels of LC3-II and RAGE, but reduced the expression of p62. In cells transfected with Atg5 and RAGE siRNA, cell viability and expression of LC3-II decreased in both the AGE-BSA and PF + AGE-BSA treatments. PF can protect HUVECs from AGE-BSA-induced injury by upregulating autophagy and promoting the completion of autophagy flux. RAGE plays an important role in this autophagic protection effect.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
最新[2023]版:
JCR分区:
出版当年[2013]版:
Q3 ONCOLOGY Q3 PATHOLOGY
最新[2023]版:
Q3 PATHOLOGY Q4 ONCOLOGY Q4 PATHOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]Department of Endocrinology, Second Affiliated Hospital of Soochow University, Suzhou 215004, China
通讯作者:
通讯机构: [*1]Department of Endocrinology, Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院